An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Several professionals stated the demand for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.
Service Reaction and Material Elimination
According to the social media company, the platform has taken down violative material and banned related hashtags and query recommendations. The company said it was dedicated to keeping the service secure and allocating resources in strengthening compliance measures.
Digital Trading Operations
Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at home.
After minutes of joining one group, a vendor shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, medical conditions or previous experience.
Item Information and Costs
Within these communities, posts show black plastic parcels with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to possibly significant medical dangers”.
